Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 136 AL 150

Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes

Valenza M, Facchinetti R, Menegoni G, Steardo L, Scuderi C.

Biomolecules. 2021 Apr 19;11(4):600. doi: 10.3390/biom11040600.

Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease

Yang AJT, Bagit A, MacPherson REK.

Int J Mol Sci. 2021 Apr 28;22(9):4628. doi: 10.3390/ijms22094628.

Anti-Alzheimer's Molecules Derived from Marine Life: Understanding Molecular Mechanisms and Therapeutic Potential

Kabir MT, Uddin MS, Jeandet P, Emran TB, Mitra S, Albadrani GM, Sayed AA, Abdel-Daim MM, Simal-Gandara J.

Mar Drugs. 2021 Apr 28;19(5):251. doi: 10.3390/md19050251.

The Clinician's Interview-Based Impression of Change (Plus caregiver input) and goal attainment in two dementia drug trials: Clinical meaningfulness and the initial treatment response

Stanley J, Howlett SE, Dunn T, Rockwood K.

Alzheimers Dement. 2021 May;17(5):856-865. doi: 10.1002/alz.12242. Epub 2021 Apr 29.

Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies

Jangampalli Adi P, Reddy PH.

Biochim Biophys Acta Mol Basis Dis. 2021 Aug 1;1867(8):166162. doi: 10.1016/j.bbadis.2021.166162. Epub 2021 Apr 30.

Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease

Alabed S, Zhou H, Sariyer IK, Chang SL.

Int J Mol Sci. 2021 Apr 30;22(9):4781. doi: 10.3390/ijms22094781.

Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

Grossmann K.

Int J Mol Sci. 2021 Apr 30;22(9):4805. doi: 10.3390/ijms22094805.

Progress with Treatments for Alzheimer's Disease

Levey AI.

N Engl J Med. 2021 May 6;384(18):1762-1763. doi: 10.1056/NEJMe2103722.

Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials

Sumsuzzman DM, Choi J, Jin Y, Hong Y.

Neurosci Biobehav Rev. 2021 Aug;127:459-473. doi: 10.1016/j.neubiorev.2021.04.034. Epub 2021 May 3.

Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment

Ke J, Tian Q, Xu Q, Fu Z, Fu Q.

Drug Discov Today. 2021 Aug;26(8):1991-2002. doi: 10.1016/j.drudis.2021.04.025. Epub 2021 May 5.

Narrative review: recent advances in doll therapy for Alzheimer's disease

Cai X, Zhou L, Han P, Deng X, Zhu H, Fang F, Zhang Z.

Ann Palliat Med. 2021 Apr;10(4):4878-4881. doi: 10.21037/apm-21-853.

Treatment of epilepsy for people with Alzheimer's disease

Liu J, Wang LN.

Cochrane Database Syst Rev. 2021 May 11;5(5):CD011922. doi: 10.1002/14651858.CD011922.pub4.

Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer's disease

Ayalon G, Lee SH, Adolfsson O, Foo-Atkins C, Atwal JK, Blendstrup M, Booler H, Bravo J, Brendza R, Brunstein F, Chan R, Chandra P, Couch JA, Datwani A, Demeule B, DiCara D, Erickson R, Ernst JA, Foreman O, He D, Hötzel I, Keeley M, Kwok MCM, Lafrance-Vanasse J, Lin H, Lu Y, Luk W, Manser P, Muhs A, Ngu H, Pfeifer A, Pihlgren M, Rao GK, Scearce-Levie K, Schauer SP, Smith WB, Solanoy H, Teng E, Wildsmith KR, Bumbaca Yadav D, Ying Y, Fuji RN, Kerchner GA.

Sci Transl Med. 2021 May 12;13(593):eabb2639. doi: 10.1126/scitranslmed.abb2639.

Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)

Ferreira JPS, Albuquerque HMT, Cardoso SM, Silva AMS, Silva VLM.

Eur J Med Chem. 2021 Oct 5;221:113492. doi: 10.1016/j.ejmech.2021.113492. Epub 2021 Apr 24.

Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies

Annadurai N, De Sanctis JB, Hajdúch M, Das V.

Exp Neurol. 2021 Sep;343:113756. doi: 10.1016/j.expneurol.2021.113756. Epub 2021 May 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias